ALPS Advisors’s KALA BIO KALA Stock Holding History

ALPS Advisors’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17	Closed	-$430K	–	907
2018 Q3	$430K	Buy	17 +3	+21%	+$91.4K	﹤0.01%	865
2018 Q2	$489K	Buy	+14	New	+$537K	﹤0.01%	594

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

ALPS Advisors's KALA Position: Q4 2018 in Review

ALPS Advisors sold out of KALA BIO (KALA) in Q4 2018, closing a stake of 17 shares — an estimated $430K sold.

ALPS Advisors first reported a position in KALA in Q2 2018 and held it in 2 quarters. The position peaked at $489K in Q2 2018. 64 funds tracked by Wall St. Rank hold KALA as of Q4 2018.

ALPS Advisors reported no remaining KALA BIO position as of Q4 2018 after selling out during the quarter.
ALPS Advisors sold 17 KALA BIO shares in Q4 2018, an estimated $430K.
ALPS Advisors first reported a position in KALA BIO in Q2 2018 and held it in 2 quarters.
ALPS Advisors's KALA BIO position peaked at $489K in Q2 2018.
64 funds tracked by Wall St. Rank held KALA BIO as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.